Share on StockTwits

Shares of Quintiles Transnational Holdings (NYSE:Q) reached a new 52-week high during trading on Monday , American Banking & Market News reports. The company traded as high as $57.65 and last traded at $57.45, with a volume of 135,074 shares changing hands. The stock had previously closed at $57.02.

A number of research firms have recently commented on Q. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Quintiles Transnational Holdings in a research note on Wednesday, August 6th. They now have a $63.00 price target on the stock, up previously from $56.00. Separately, analysts at Raymond James raised their price target on shares of Quintiles Transnational Holdings from $62.00 to $64.00 in a research note on Tuesday, August 5th. They now have a “strong-buy” rating on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Quintiles Transnational Holdings in a research note on Friday, August 1st. They now have a $65.00 price target on the stock, up previously from $60.00. Four analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Quintiles Transnational Holdings currently has a consensus rating of “Buy” and a consensus price target of $60.09.

The stock’s 50-day moving average is $55.19 and its 200-day moving average is $51.91. The company has a market cap of $7.265 billion and a P/E ratio of 24.10.

Quintiles Transnational Holdings (NYSE:Q) last announced its earnings results on Thursday, July 31st. The company reported $0.65 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.60 by $0.05. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the company posted $0.50 earnings per share. Quintiles Transnational Holdings’s revenue was up 9.6% compared to the same quarter last year. Analysts expect that Quintiles Transnational Holdings will post $2.64 EPS for the current fiscal year.

Quintiles Transnational Holdings Inc, is a provider of biopharmaceutical development services and commercial outsourcing services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.